Span Divergent Sells Stake in Inactive Subsidiary, Explores Fund-Raising Options
Span Divergent Limited has announced several corporate actions following its board meeting on November 10, 2025. The company will divest its 99% stake in Span Diagnostics LLP to promoters for INR 99,000. The board approved exploring fund-raising options including FPO and Preferential Allotment. Management changes include appointing Mr. Dharmesh Vinodbhai Desai as an Additional Non-Executive Independent Director and resignations of two other directors. The company plans to revive operations of its subsidiary, Aranya Agri Biotech LLP. For Q2 FY2026, Span Divergent reported a consolidated total income of INR 786.26 lakhs, up 157.53% YoY, but recorded a net loss of INR 18.77 lakhs compared to a profit in Q2 FY2025.

*this image is generated using AI for illustrative purposes only.
Span Divergent Limited , formerly known as Span Diagnostics Limited, has announced several significant corporate actions following its board meeting on November 10, 2025. The company has made strategic decisions aimed at streamlining its operations and strengthening its financial position.
Divestment of Subsidiary Stake
The board has approved the sale of Span Divergent's entire 99% stake in its subsidiary, Span Diagnostics LLP, to promoters Mr. Viral P Desai and Ms. Sujata V Desai for INR 99,000. This decision comes after shareholders approved the transaction on September 26, 2024. The subsidiary has been inoperative since its inception and contributed no income or net worth during the financial year 2024-2025.
| Details of Divestment | Information |
|---|---|
| Subsidiary Name | Span Diagnostics LLP |
| Stake Sold | 99% |
| Sale Price | INR 99,000 |
| Buyers | Mr. Viral P Desai, Ms. Sujata V Desai |
| Transaction Date | November 10, 2025 |
Despite the buyers being part of the promoter group, the company stated that the transaction is being conducted at arm's length price.
Exploration of Fund-Raising Options
Span Divergent's board has approved the exploration of various fund-raising avenues to bolster its financial position and support future growth initiatives. The company is considering options including a Fresh Public Offer (FPO), Preferential Allotment, or other appropriate modes.
The management has been authorized to evaluate alternatives, assess market conditions, and engage professional advisors and merchant bankers to assist in the process. However, the company emphasized that no definitive decision has been made regarding the structure, size, or timing of any proposed fund-raising at this stage.
Board and Management Changes
The company announced several changes to its board composition:
- Appointment of Mr. Dharmesh Vinodbhai Desai as an Additional Non-Executive Independent Director for a five-year term, subject to shareholder approval.
- Resignation of Mr. Nirav Dineshchandra Jogani as an Independent Director.
- Resignation of Dr. Pradipkumar Keshavlal Desai as Non-Executive and Non-Independent Director, who will continue as "Chairman Emeritus" in an advisory role.
Subsidiary Operations
The board has approved a plan to revive operations of its subsidiary, M/s. Aranya Agri Biotech LLP, reclassifying its assets as part of Property, Plant and Equipment (PPE) in light of new business opportunities.
Financial Performance
For the quarter ended September 30, 2025, Span Divergent reported the following consolidated results:
| Financial Metric | Q2 FY2026 (INR Lakhs) | Q2 FY2025 (INR Lakhs) | YoY Change |
|---|---|---|---|
| Total Income | 786.26 | 305.31 | +157.53% |
| Net Profit/(Loss) | (18.77) | 4.65 | N/A |
The company's revenue saw a significant increase, but it reported a loss compared to a profit in the same quarter of the previous year.
These strategic moves and financial results reflect Span Divergent's efforts to optimize its corporate structure and explore growth opportunities amidst challenging market conditions.
Historical Stock Returns for Span Divergent
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.68% | +27.14% | +23.65% | +32.51% | +16.24% | +204.47% |





























